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cD4+ T-cell-independent secondary 
immune responses to Pneumocystis 
Pneumonia
Nicholas M. de la Rua†, Derrick R. Samuelson†, Tysheena P. Charles, David A. Welsh 
and Judd E. Shellito*
Section of Pulmonary/Critical Care and Allergy/Immunology, Department of Medicine, Louisiana State University Health 
Sciences Center, New Orleans, LA, USA
Pneumocystis pneumonia is a major cause of morbidity and mortality among immuno-
compromised patients, especially in the context of HIV/AIDS. In the murine model of 
Pneumocystis pneumonia, CD4+ T-cells are required for clearance of a primary infection 
of Pneumocystis, but not the memory recall response. We hypothesized that the memory 
recall response in the absence of CD4+ T-cells is mediated by a robust memory humoral 
response, CD8+ T-cells, and IgG-mediated phagocytosis by alveolar macrophages. To 
investigate the role of CD8+ T-cells and alveolar macrophages in the immune mem-
ory response to Pneumocystis, mice previously challenged with Pneumocystis were 
depleted of CD8+ T-cells or alveolar macrophages prior to re-infection. Mice depleted 
of CD4+ T-cells prior to secondary challenge cleared Pneumocystis infection within 
48 h identical to immunocompetent mice during a secondary memory recall response. 
However, loss of CD8+ T-cells or macrophages prior to the memory recall response 
significantly impaired Pneumocystis clearance. Specifically, mice depleted of CD8+ 
T-cells or alveolar macrophages had significantly higher fungal burden in the lungs. 
Furthermore, loss of alveolar macrophages significantly skewed the lung CD8+ T-cell 
response toward a terminally differentiated effector memory population and increased 
the percentage of IFN-γ+ CD8+ T-cells. Finally, Pneumocystis-infected animals produced 
significantly more bone marrow plasma cells and Pneumocystis-specific IgG significantly 
increased macrophage-mediated killing of Pneumocystis in vitro. These data suggest 
that secondary immune memory responses to Pneumocystis are mediated, in part, by 
CD8+ T-cells, alveolar macrophages, and the production of Pneumocystis-specific IgG.
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inTrODUcTiOn
Pneumonia due to the opportunistic human fungal pathogen Pneumocystis jirovecii is an AIDS-
defining illness, and there is a direct inverse relationship between CD4+ T-cell counts in the blood 
and the risk for infection (1). Pneumocystis is also a major cause of mortality in patients whose CD4+ 
T-cell number or function is significantly depressed due to malignancy, chemotherapy, or other 
immunosuppression (1, 2). Animal models of immunodeficiency demonstrate that the loss of CD4+ 
T-cells renders mammals susceptible to Pneumocystis lung infection (2). Additionally, CD4+ T-cells 
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from Pneumocystis-infected mice are able to mediate clearance of 
Pneumocystis infection upon adoptive transfer into Rag1(−/−) mice 
(3). As such, CD4+ T-cells have been a primary focus in the study 
of host defense against this pathogen.
However, it has also been shown that adoptive transfer of 
hyperimmune serum mediates effective passive immunity to 
Pneumocystis in the absence of T cells (4). Further, Gigliotti 
and colleagues have shown that immunocompetent mice 
immunized against Pneumocystis by intratracheal inoculations 
with Pneumocystis are protected from subsequent lung infection 
following depletion of CD4+ T cells with anti-CD4 monoclonal 
antibodies, which suggests that CD4+ T-cells are not required for 
the memory recall response (5). In addition, these investigators 
demonstrated that antibodies are responsible for the observed 
protection against P. carinii in the absence of CD4+ T cells (5). 
These results suggest that CD4+ T-cells are not required for sec-
ondary immune recall to Pneumocystis infection. These results 
also suggest that more focus should be given to immune cells 
other than CD4+ T-cells in host defense against Pneumocystis. 
This is highlighted by the fact that exposure to Pneumocystis is 
ubiquitous in humans and that the memory response to infection 
is often called into play in the context of CD4+ T-cell depletion 
(HIV infection).
In this study, we evaluated the cellular immune memory recall 
response to murine Pneumocystis infection in the absence of 
CD4+ T-cells. Specifically, we depleted CD8+ T-cells or alveolar 
macrophages prior to a secondary infection and evaluated the 
host’s memory response to Pneumocystis infection. Mice depleted 
of CD4+ T-cells prior to secondary challenge cleared Pneumocystis 
infection within 48 h identical to immunocompetent mice during a 
secondary memory recall response. However, loss of CD8+ T-cells 
or macrophages prior to the memory recall response significantly 
impaired Pneumocystis clearance. Specifically, mice depleted of 
CD8+ T-cells or alveolar macrophages had significantly higher 
fungal burden in the lungs, and loss of alveolar macrophages 
significantly increased the percentage of IFN-γ+ CD8+ T-cells. 
Finally, Pneumocystis-infected animals generated significantly 
more bone marrow plasma cells, and Pneumocystis-specific 
IgG purified from sera of previously infected mice significantly 
increased macrophage-mediated killing of Pneumocystis in vitro. 
These data suggest that secondary immune memory responses to 
Pneumocystis are mediated, in part, by CD8+ T-cells and alveolar 
macrophages, in addition to the production of Pneumocystis-
specific IgG.
MaTerials anD MeThODs
immune Memory Model
Pneumocystis murina was propagated in B10;B6 Rag2/IL2rg 
double knockout mice from Taconic (Model 4111F; Hudson, 
NY, USA). Inocula and naive lung homogenates were prepared 
as previously described (2), and recipient mice were infected, as 
previously described (6). C57Bl/6 female mice (6–8 weeks) were 
either intratracheally challenged with 2 × 105 cysts or naive lung 
homogenate. Mice were depleted of CD4+ T-cells, CD8+ T-cells, 
or macrophages at the indicated time points prior to infection 
by intraperitoneal (i.p.) injection with 100 μg of anti-CD4 mAb 
(hybridoma GK 1.5; Taconic), 100 μg of anti-CD8 mAb (hybri-
doma 58.6.72; National Cell Culture Center), or intratracheal 
administration (i.t.) of 100 μL of clodronate liposomes (http://
clodronateliposomes.com; Netherlands). Control animals were 
given IgG isotype control via i.p. injection or PBS containing 
empty liposomes via i.t. inoculation. Depletions were maintained 
by dosing animals every 6 days, which is sufficient to maintain 
significant cellular depletion (data not shown).
Quantitation of Pneumocystis-specific igg
Whole blood was either collected from tail bleeds or cardiac 
puncture, and serum was obtained via centrifugation of whole 
blood in BD serum separator tubes at 1,500 × g for 10 min at 
4°C. Serum was stored at −20°C. Pneumocystis whole cell 
lysate was used to quantify the IgG humoral response. In brief, 
Pneumocystis-infected lungs from B10;B6 Rag2/IL2rg double 
knockout mice were homogenized over a 70-μm filter and 
washed with chilled magnesium-free PBS supplemented with 5% 
glutathione. The filtrate was centrifuged at 300 × g for 10 min, 
and the pellet was resuspended in approximately 1 mL of residual 
supernatant. The resuspended pellet was then pipetted on top of 
30 mL of 1:2 Centricoll (density ~1.40; Sigma C-0580) diluted 
in PBS. The preparation was centrifuged for 15 min at 275 × g. 
Pneumocystis organisms were collected from the PBS–Centricoll 
interphase and were washed with PBS containing 5% glutathione. 
The pellet was then sonicated using a water bath sonicator. Total 
protein was quantified using Nanodrop spectrophotometer. 
Total Pneumocystis-specific IgG was quantified using Mouse 
IgG Total ELISA Ready-SET-Go Kit (Affymetrix eBiosciences). 
Pneumocystis whole cell lysate was coated on a Thermo Scientific 
Nunc 96-well flat bottom plates at 5 μg/mL in 50 μL of 0.1M 
Na2CO3/0.1M NaHCO3 (pH 9.5) per well. The plates were incu-
bated overnight at 4°C. Wells were aspirated and washed twice 
with PBS 0.05% Tween20. Plates were blocked according to the 
manufacture’s protocol. Serum was diluted 1:500 and allowed 
to incubate in the presence of anti-mouse IgG HRP-conjugated 
detection antibodies for 3 h at room temperature with shaking at 
400 rpm. Plates were aspirated and washed four times. Plates were 
developed with TMB solution for 15 min at room temperature; 
the reactions were stopped via the addition of 2 N H2SO4. Optical 
density (OD) was recorded at 450 nm with a BioTek ELX800 plate 
reader. Values are reported as the mean OD450 ± SEM with the 
value of the control wells (BSA coated) subtracted.
Quantitation of Pneumocystis 
Fungal Burden
The right lung was placed in 1 mL of Trizol and briefly stored 
at −20°C. RNA was extracted from each lung following the 
manufacturer’s protocol. RNA was quantified using a Nanodrop 
spectrophotometer. cDNA was synthesized from 1 μg of Lung 
RNA using BioRad Reverse Transcription Supermix for RT-qPCR 
following the manufacturer’s protocol. Pneumocystis fungal bur-
den was assayed via amplifying a 166-bp fragment of the small 
ribosomal rRNA (ssRNA) from the mitochondrial genome, as 
described previously (6, 7).
3de la Rua et al. Secondary Immune Responses to Pneumocystis
Frontiers in Immunology | www.frontiersin.org May 2016 | Volume 7 | Article 178
Flow cytometric analysis of T-cells, 
B-cells, and Macrophages in the lung
Left lung tissue was homogenized over a 70-μm filter with 
10  mL of homogenization buffer that comprised RPMI 
1640 10% FBS, 1  mg/mL collagenase type 1 (Worthington 
Biochemical, Lakewood, NJ, USA), and 30  μg/mL DNAse I 
(Roche Diagnostics, Indianapolis, IN, USA). Lung homogenates 
were incubated at 37°C with shaking at 200 rpm for 30 min. All 
cell suspensions were centrifuged at 300 × g for 10 min at 4°C. 
Cells were resuspended in 5 mL of chilled 1× RBC lysis buffer 
(Biolegend, San Diego, CA, USA) for 4 min on ice. RBC lysis 
reactions were diluted with 25-mL chilled PBS. Lymphocytes 
were enumerated using a hemocytometer and trypan blue 
exclusion. Prior to all extracellular staining, cells were treated 
with TruStain fcX (Biolegend) to block Fc receptors. To conduct 
extracellular phenotype studies, 1 × 106 cells were stained with 
various combinations of the following fluorochrome-conjugated 
Abs specific for murine CD3, CD4, CD8, CD19, CD28, CD45, 
CD45RA, CD197 (CCR7), CD11b, CD11c, and Zombie NIR 
(Biolegend) suspended in MACS buffer (Miltenyi Biotec, San 
Diego, CA, USA) at the manufacturer’s recommended concen-
trations for 30 min at 4°C.
Pan T-cell, B-cells, and macrophages in the lung were assayed 
by gating singlet events (FSH vs. FSA), lymphocyte size gate 
(FSC vs. SSC), and selecting viable CD45+ events indicated by a 
CD45 expression and lack of uptake of Zombie NIR, intracellular 
uptake of this dye indicates cell death. T-cells were enumerated 
as a percent of CD45+ live events by gating on CD3+, CD4+, and 
CD8a+ expression. B-cells were enumerated as a percentage of 
CD45+ live events by gating on CD45+CD19+ expression. Alveolar 
macrophages were enumerated as a percentage of CD45+ live 
events by gating on CD11c+CD11b− events. These data provided 
evidence of successful depletion and of cellular response to sec-
ondary infection with Pneumocystis.
In order to assess the CD8+ T-cell response to secondary infec-
tion with Pneumocystis, four extracellular phenotypes for CD8+ 
T-cells were defined as naive (CD45+CD3+CD4−CD8+CD45RA+
CD28+), central memory (CD45+CD3+CD4−CD8+CD45RA−CD
197+), effector memory (CD45+CD3+CD4−CD8+CD45RA−CD1
97−), and terminally differentiated effector memory re-expressing 
CD45RA (CD45+CD3+CD4−CD8+CD45RA+CD28−) cells.
For intracellular staining (ICS) experiments, cells were 
resuspended in BD GolgiPlug and incubated for 5 h. Following 
GolgiPlug treatment, cells were stained with TruStain fcX 
(Biolegends) for 5 min prior to extracellular staining with CD45, 
CD3, CD4, and CD8 antibodies. Cells were then washed with 
FACS buffer, and resuspended in Cytofix/Cytoperm (Fixation/
Permeablization Kit; BD Biosciences) and incubated for 
20 min, as per the manufacturer’s instructions. Cells were then 
resuspended in 1× Permwash and incubated for 5 min at room 
temperature. After washing, cells were incubated for 30 min at 
4°C with fluorescently labeled anti-mouse IFN-γ, IL-4, IL-17, or 
GM-CSF antibodies (Biolegend, San Diego, CA, USA), diluted 
in Permwash at appropriate concentrations. Wells were then 
washed with FACS buffer and fixed with PBS + 1% formalin. For 
all experiments, cells were acquired using LSRII flow cytometer 
(BD Biosciences, San Jose, CA, USA). All analyses of FACS data 
were performed using FlowJo software Version 9.4 (Tree Star; 
Ashland, OR, USA). Intracellular phenotyping is presented as a 
percentage of CD45+, CD3+CD4+, or CD45+CD3+CD8+ events.
isolation and culture of Bone Marrow 
Plasma cells to assess Their generation 
after infection and Potential secretion of 
Pneumocystis-specific igg
In order to assess whether infection with Pneumocystis gener-
ates Pneumocystis-specific bone marrow plasma cells (BMPCs), 
BMPCs were enumerated using flow cytometry and cultured. 
BMPCs (CD45R−CD138+) are long-lived cells that secrete 
neutralizing antibody after exposure to antigen. As terminally 
differentiated B-cells of the bone marrow compartment, they 
do not survive or secrete antibody in vitro without the support 
of mesenchymal stem cells (MSCs). Mouse MSCs were isolated 
from the femur and the tibia of uninfected animals, as described 
previously (8). Specifically, the epiphysis from each bone was 
removed and the bone marrow from the diaphysis was flushed 
with a 26-gage needle with a syringe filled with culture media, 
making sure that the bone was flushed completely. Bones were 
then cut into small chips ~1–3  mm in size and treated with 
DMEM containing 20% FBS and collagenase II (1 mg/mL) for 
1 h at 37°C with shaking at 200 rpm. The bone chips were then 
resuspended in 10 mL of DMEM containing 20% FBS and 0.1% 
penicillin–streptomycin for 5 days in a T-25 flask and monitored 
for mesenchymal cell migration from bone chips and growth onto 
the flask. After sufficient migration from bone chips (~5–7 days), 
cells were passed into a T75 flask and maintained in culture for 
the rest of the experiment.
In order to quantify total BMPCs, mouse BMPCs were 
enriched from total bone marrow cells via the mouse CD138+ 
Plasma Cell Isolation Kit (Miltenyi Biotec). Briefly, cells were 
resuspended in MACS buffer and incubated with 100  μL of 
CD138 Microbeads per 108 total cells for 15  min at 4–8°C. 
Cells were then washed and resuspended in 500 μL of MACS 
buffer. Plasma cells were then obtained by placing a MS col-
umn (Miltenyi Biotec) in the magnetic field of an octoMACs 
separator (Miltenyi Biotec) and applying the labeled cells to the 
column and washing two times with MACS buffer. Plasma cells 
were collected by removing the column from the magnetic field 
and eluting with MACs buffer. BMPCs were further purified 
via flow cytometric sorting. Briefly, purified BMPCs were incu-
bated Fc block prior to staining with anti-mouse CD138 and 
anti-mouse/human CD45R/B220 for 30 min at 4°C. Cells were 
then washed and resuspended in MACS buffer for flow sorting. 
Enriched BMPCs (CD138+/CD45R−) were sorted directly into 
culture media and immediately cultured. Magnetically and flow 
cytometric-sorted CD138+ BMPCs were immediately cocul-
tured with 5 × 103 MSCs in 96-well plates in DMEM containing 
20% FBS and 0.1% pen–strep. After 72  h, supernatant was 
collected from wells containing MSCs, BMPCs, or cocultured 
BMPCs and MSCs, and Pneumocystis-specific IgG was quanti-
fied as described above.
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Purification of Pneumocystis-specific 
Mouse igg
Sera from animals previously infected with Pneumocystis or sera 
from uninfected animals were pooled and desalted using the 
Zeba desalting columns (Life Technologies), as per the manu-
facturer’s instructions. Desalted sera were then used to purify 
IgG using the Melon Gel Purification Kit (Life Technologies 
Corporation, Grand Island, NY, USA) as per the manufac-
turer’s instructions. Purified IgG was then quantified using a 
Nanodrop spectrophotometer and used for in vitro macrophage 
killing assays.
Macrophage-Mediated Pneumocystis 
Killing assay
MH-S alveolar macrophages were acquired from ATTC (ATCC® 
CRL-2019™). MH-S cells were maintained in complete media 
(RPMI 1640 containing 0.05-mM 2-mercaptoethanol and 10% 
FBS) and were passed every 2–3 days throughout the experi-
ment. Macrophage-mediated Pneumocystis killing assays were 
performed by plating 100,000 Pneumocystis cysts and 100,000 
alveolar macrophages (1:1 ratio) per well in a 96-well flat 
bottom plate. Each experimental group was run in sextuplet. 
Purified immune IgG or naive IgG was then added to the wells 
at the following concentrations (0.002, 0.004, and 0.008 μg), 
and cultures were incubated for 24 h. Control wells contained 
cysts +  macrophages without the addition of IgG. Following 
incubation, 250  μL of Trizol was added to each well and 
incubated for 5 min and repeated one more time. RNA extrac-
tions and Pneumocystis enumeration were then performed as 
described above.
statistical analysis
Results are presented as mean ± SEM. Statistical analyses were 
performed using GraphPad Prism 5 (La Jolla, CA, USA), and sta-
tistical significance was measured at P ≤ 0.05. The non-parametric 
Kruskal–Wallis one-way analysis of variance (ANOVA), followed 
by post hoc Dunn’s multiple comparisons of the means, was used 
for all in vivo assays.
resUlTs
immune Memory recall Does not require 
cD4+ T-cells
To evaluate the immune memory recall responses to Pneumocystis 
pneumonia, we first investigated the requirement of CD4+ T-cells 
during secondary immune responses, as well as establishment 
of cellular and humoral immune memory. C57BL/6 mice were 
grouped into the following categories: uninfected animals (desig-
nated none), immune-intact animals (isotype), and three groups 
of mice depleted of CD4+ T cells. CD4 depletion was maintained: 
(a) prior to primary infection and continuously throughout the 
experiment (cont.), (b) only prior to a primary infection (1°), or 
(c) only prior to a secondary infection (2°). Mice were infected 
intratracheally with live P. murina (~2 × 105 cysts in 100 μL of PBS) 
and were allowed to clear the infection naturally (isotype, 1° and 
2°) or were given Bactrim (trimethoprim and sulfamethoxazole) 
ad  libitum in the water (cont.), following 4 weeks of persistent 
infection. All mice had no detectable P. murina in lung tissue 
by qPCR prior to re-infection (not shown). Animals were then 
re-infected with P. murina (~2 × 105 cysts in 100 μL of PBS) and 
pathogen clearance, P. murina-specific IgG, and lung immune 
responses were evaluated.
Figure  1A describes the experimental design used in this 
study. P. murina-specific IgG in the serum was assayed by ELISA 
(Figure 1B). Levels of P. murina in the lung following secondary 
infection at the following time points: 2 days post-lung infection 
(Figure 1C), 4 days post-lung infection (Figure 1D), and 6 days 
post-lung infection (Figure  1E) were assessed via qPCR. We 
also assessed the levels of CD4+ T cells (Figure 1F), CD8+ T cells 
(Figure 1G), and CD19+ B cells (Figure 1H) in the lungs using 
flow cytometry. The representative gating strategy to determine 
the number of CD4+ T cells, CD8+ T cells, and CD19+ B cells is 
shown in Figure  1I. We found that CD4+ T-cells are required 
to generate Pneumocystis-specific IgG, but are not required for 
IgG recall responses during re-infection (Figure 1B). Secondary 
immune memory responses do not require CD4+ T-cells, as the 
levels of P. murina in the lung did not significantly differ from 
immune-intact animals (Figures 1C–E). However, CD4+ T-cells 
are required for generation of immune memory, as mice depleted 
of CD4+ T-cells prior to a primary infection or continuously 
depleted are unable to mount an effective memory immune 
response (Figures 1C–E). In fact, mice continuously depleted of 
CD4+ T-cells do not generate any immune memory, as indicated 
by fungal burden and IgG levels identical to CD4-depleted 
animals experiencing P. murina infection for the first time. In 
addition, evaluation of the immune cell populations in the lungs 
following secondary infection showed a significant increase in the 
number of CD8+ T-cells and CD19+ B-cells in animals depleted 
of CD4+ T-cells prior to a secondary infection (Figures 1G,H). 
Levels of CD8+ T-cells and CD19+ B-cells in mice depleted of 
CD4+ T-cells prior to a secondary infection were similar to those 
observed in immune-intact animals, suggesting that CD8+ T-cells 
and CD19+ B-cells may be important for a maximal secondary 
immune response. These results further indicate that secondary 
immune memory responses do not require CD4+ T-cells, but that 
the development of protective memory does require CD4+ T-cells 
during a primary infection. We then went on to investigate other 
cellular populations that could be involved in secondary immune 
memory responses to Pneumocystis.
Maximal host Defense against secondary 
infection requires cD8+ T-cells and 
alveolar Macrophages
Mice were infected with P. murina as described above, and groups 
of mice were depleted of CD4+ T cells, CD8+ T-cells, CD4+/
CD8+ T-cells, macrophages, and CD4+ T-cells/macrophages 
every 6 days with depletion occurring prior to secondary infec-
tion (2°). Levels of P. murina in the lung following secondary 
infection at the following time points: 2 days post-lung infec-
tion (Figure 2A), 4 days post-lung infection (Figure 2B), and 
6  days post-lung infection (Figure  2C) were determined via 
FigUre 1 | continued
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qPCR. Additionally, the levels of lung CD4+ T cells (Figure 2D), 
CD8+ T cells (Figure  2D), and CD11c+CD11b− macrophages 
(Figure  2D) were quantified via flow cytometry. P. murina-
specific IgG in the serum was also assessed (Figure  2E). The 
representative gating strategy to determine the number of CD4+ 
T cells, CD8+ T cells, and CD11c+CD11b− macrophages is shown 
in Figure 2F. Flow cytometric analysis demonstrated that all tar-
geted immune cell populations in each group were significantly 
depleted prior to re-infection (Figures  2D,F). Further, loss of 
CD4+ T cells, CD8+ T-cells, macrophages, CD4+ and CD8+ T cells, 
or CD4+ T cells and macrophages did not significantly affect the 
levels of Pneumocystis-specific IgG after re-challenge, suggesting 
that the humoral response is still intact (Figure 2E). However, 
mice depleted of CD8+ T-cells prior to secondary infection with 
P. murina had a significant increase in lung burden compared to 
either CD4-depleted or immune-intact animals at 2 and 4 days 
post-infection (DPI) (Figures  2A,B), despite similar amounts 
of Pneumocystis-specific IgG when compared to immune-intact 
animals. Similarly, mice depleted of macrophages exhibited a 
significantly increased level of P. murina in the lungs compared 
to control mice at 2 and 4 DPI (Figures 2A,B). However, mice 
depleted of CD8+ T-cells or macrophages cleared lung infection 
at 6 DPI (Figure 2C), suggesting that the cellular recall response 
is not essential for secondary host defense against Pneumocystis 
infection. These data also suggest that the immune memory 
response to Pneumocystis is, in part, mediated by CD8+ T-cells 
and macrophages, but that CD4+ T-cells play little role. We then 
sought to examine the cellular phenotypes associated with CD4+ 
T-cells and CD8+ T-cells during secondary immune responses 
to Pneumocystis.
loss of cD8+ T-cells or alveolar 
Macrophages Delays iFn-γ Production by 
cD4+ T-cells in secondary immune 
responses to Pneumocystis
Mice were infected with P. murina as described above, and 
groups of mice were depleted of CD8+ T-cells and macrophages 
every 6 days with depletion occurring prior to secondary infec-
tion (2°). Lung CD4+ T-cell subsets were then examined at 2 
and 4 days post-secondary infection: GM-CSF+ CD4+ T cells 
(Figures 3A,E, respectively), IL-4+ CD4+ T cells (Figures 3B,F, 
respectively), IFN-γ+ CD4+ T cells (Figures  3C,G, respec-
tively), and IL-17+ CD4+ T cells (Figures 3D,H, respectively). 
FigUre 1 | immune memory recall does not require cD4+ T-cells. (a) Schematic outline of the experimental protocol used in this study. C57BL/6 mice were 
infected intratracheally with live P. murina (~2 × 105 cysts in 100 μL of PBS). Three groups of mice were depleted of CD4+ T cells every 6 days with CD4+ T-cell 
depletion occurring continuously throughout the experiment (cont.) or prior to primary infection (1°) or prior to secondary infection (2°). (B) P. murina-specific IgG in 
the serum was assayed by ELISA. Levels of P. murina in the lung following secondary infection at the following time points: (c) 2 days post-lung infection, (D) 4 days 
post-lung infection, and (e) 6 days post-lung infection via qPCR. Lung immunological responses: (F) CD4+ T cells, (g) CD8+ T cells, and (h) CD19+ B cells were 
quantified via flow cytometry. (i) Representative gating strategy used for flow cytometry analysis. Dots and bars represent mean ± SEM, N = 5 at each time points, 
* indicates P < 0.05, when comparing isotype to sham-infected animals and # indicates P < 0.05, when comparing CD4 (2°) to sham-infected animals, for each of 
the indicated time point, by Kruskal–Wallis ANOVA followed by Dunn’s posttest. DPPI, days post-primary infection; DPSI, days post-secondary infection.
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The gating strategy used to determine the various CD4+ 
T-cell phenotypes are depicted in Figure  3I. The percentage 
of GM-CSF+, IL-17+, or IL-4+ CD4+ T cells in the lung 2 or 
4  DPI in immune-intact animals did not significantly differ 
from CD8-depleted animals or macrophage-depleted mice. 
Conversely, loss of CD8+ T-cells or macrophages significantly 
decreased the percentage of IFN-γ+ CD4+ T cells compared 
to control animals 2  DPI. However, by 4  DPI, there was a 
significant increase in the percentage of IFN-γ+ CD4+ T cells 
compared to control animals.
FigUre 2 | Maximal immune memory recall requires cD8+ T-cells and alveolar macrophages. C57BL/6 mice were infected intratracheally with live P. 
murina (~2 × 105 cysts in 100 μL of PBS), and groups of mice were depleted of CD4+ T cells, CD8+ T-cells, CD4+ and CD8+ T-cells, macrophages, or CD4+ T-cells 
and macrophages every 6 days with depletion occurring prior to secondary infection (2°). Levels of P. murina in the lung following secondary infection at the 
following time points: (a) 2 days post-lung infection, (B) 4 days post-lung infection, and (c) 6 days post-lung infection was assessed via qPCR. Lung immunological 
responses: (D) CD4+ T cells, CD8+ T cells, and CD11c+CD11b− macrophages were quantified via flow cytometry. (e) P. murina-specific IgG, in the serum was 
assayed by ELISA. (F) Representative gating strategy used for flow cytometry analysis. Dots and bars represent mean ± SEM, N = 10–15 at each time points,  
* indicates P < 0.05, for the indicated comparisons for each of the indicated time point, by Kruskal–Wallis ANOVA followed by Dunn’s posttest. DPPI, days 
post-primary infection; DPSI, days post-secondary infection.
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FigUre 3 | loss of cD8+ T-cells or alveolar macrophages delays iFn-γ production by cD4+ T-cells in secondary immune responses to Pneumocystis. 
C57BL/6 mice were infected intratracheally with live P. murina, and groups of mice were depleted of CD8+ T-cells and macrophages every 6 days with depletion 
occurring prior to secondary infection (2°). Lung CD4+ T-cell subsets: GM-CSF+CD4+ T cells at 2 and 4 days post-secondary infection [(a,e), respectively], IL-4+ 
CD4+ T cells at 2 and 4 DPI [(B,F), respectively], IFN-γ+CD4+ T cells at 2 and 4 DPI [(c,g), respectively], and IL-17+CD4+ T cells at 2 and 4 DPI [(D,h), respectively], 
were quantified via flow cytometry. (i) Representative gating strategy used for flow cytometry analysis. Dots and bars represent mean ± SEM, N = 10 at each time 
points, * indicates P < 0.05, for the indicated comparisons for each of the indicated time point, by Kruskal–Wallis ANOVA followed by Dunn’s posttest. DPSI, days 
post-secondary infection.
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Maximal cD8+ T-cell response requires 
alveolar Macrophages but not  
cD4+ T-cells
We then assessed the composition and quantity of various lung 
CD8+ T-cell subsets. We first examined the levels of naive CD8+ T 
(Figures 4A,E), central memory CD8+ T (Figures 4B,F), effector 
memory CD8+ T cells (Figures 4C,G), and terminally differenti-
ated effector memory (TEMRA) CD8+ T cells (Figures 4D,H) in 
mice depleted of CD4+ T-cells, alveolar macrophages, or CD4+ 
T-cells and alveolar macrophages prior to a secondary infection 
at 2 and 4 days post-secondary infection. The gating strategy used 
to determine the various CD8+ T-cell phenotypes are depicted in 
Figure 4I. We defined the CD8+ T-cell subsets as naive (CD45+C
D3+CD4−CD8+CD45RA+CD28+), central memory (CD45+CD3+
CD4−CD8+CD45RA−CD197+), effector memory (CD45+CD3+C
D4−CD8+CD45RA−CD197−), and TEMRA (CD45+CD3+CD4−C
D8+CD45RA+CD28−). Interestingly, loss of CD4+ T-cells did not 
significantly affect the percentage of any of the CD8+ T-cell sub-
sets, suggesting that CD8+ T-cell immune memory remains active 
despite loss of CD4+ T-cells. However, mice depleted of alveolar 
macrophages prior to a secondary infection exhibited a significant 
decrease in the percentage of effector memory CD8+ T-cells, as 
well as a significant increase in the percentage of TEMRA CD8+ 
T cells at both 2 and 4 DPI. We also found that mice depleted 
of macrophages and CD4+ T-cells prior to a secondary infection 
exhibited a significant decrease in the amount of naive CD8+ 
T-cells at 2 DPI, and this trend remained at 4 DPI. The percentage 
of central memory CD8+ T cells in the lung 2 DPI in immune-
intact animals did not significantly differ from CD4-depleted 
animals or macrophage-depleted mice. However, by 4 DPI, the 
percentage of central memory CD8+ T cells significantly decreased 
in macrophage-depleted mice. These results suggest that loss 
of CD4+ T-cells does not affect the immune memory response 
FigUre 4 | Maximal cD8+ T-cell response require alveolar macrophages but not cD4+ T-cells. Mice were infected intratracheally with P. murina, and groups 
of mice were depleted of CD4+ T-cells, macrophages, or CD4+ T-cells and macrophages every 6 days with depletion occurring prior to secondary infection (2°). 
Lung CD8+ T-cell subsets: naive CD8+ T cells at 2 and 4 days post-secondary infection [(a,e), respectively], central memory CD8+ T cells at 2 and 4 DPI [(B,F), 
respectively], effector memory CD8+ T cells at 2 and 4 DPI [(c,g), respectively], and TEMRA CD8+ T cells at 2 and 4 DPI [(D,h), respectively] were quantified via flow 
cytometry. (i) Representative gating strategy used for flow cytometry analysis. Dots and bars represent mean ± SEM, N = 10 at each time points, * indicates 
P < 0.05, for the indicated comparisons for each of the indicated time point, by Kruskal–Wallis ANOVA followed by Dunn’s posttest. DPSI, days post-secondary 
infection.
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FigUre 5 | loss of alveolar macrophages increases iFn-γ production by cD8+ T-cells in secondary immune responses to Pneumocystis. C57BL/6 mice 
were infected with P. murina, and depleted of CD4+ T-cells, macrophages, or CD4+ T-cells and macrophages every 6 days with depletion occurring prior to secondary 
infection (2°). Lung CD8+ T-cell subsets: GM-CSF+ CD8+ T cells at 2 and 4 days post-secondary infection [(a,e), respectively], IL-4+ CD8+ T cells at 2 and 4 DPI [(B,F), 
respectively], IFN-γ+ CD8+ T cells at 2 and 4 DPI [(c,g), respectively], and IL-17+ CD8+ T cells at 2 and 4 DPI [(D,h), respectively] were quantified via flow cytometry. 
(i) Representative gating strategy used for flow cytometry analysis. Dots and bars represent mean ± SEM, N = 10 at each time points, * indicates P < 0.05, for the 
indicated comparisons for each of the indicated time point, by Kruskal–Wallis ANOVA followed by Dunn’s posttest. DPSI, days post-secondary infection.
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of CD8+ T-cells, but that loss of macrophages or loss of both 
macrophages and CD4+ T-cells drives the CD8+ T-cell response 
toward a terminally differentiated effector memory phenotype.
loss of alveolar Macrophages increases 
iFn-γ Production by cD8+ T-cells in 
secondary immune responses 
to Pneumocystis
Mice were infected with P. murina as described above, and 
groups of mice were depleted of CD4+ T-cells and macrophages 
every 6 days with depletion occurring prior to secondary infec-
tion (2°). Lung CD8+ T-cell subsets were then examined at 2 
and 4  days post-secondary infection: GM-CSF+ CD8+ T cells 
(Figures 5A,E, respectively), IL-4+ CD8+ T cells (Figures 5B,F, 
respectively), IFN-γ+ CD8+ T cells (Figures 5C,G, respectively), 
and IL-17+ CD8+ T cells (Figures 5D,H, respectively). The gating 
strategy used to determine the various CD8+ T-cell phenotypes 
are depicted in Figure 5I. The percentage of GM-CSF+, IL-17+, 
or IL-4+ CD8+ T cells in the lung 2 or 4 DPI in immune-intact 
animals did not significantly differ from CD4-depleted animals 
or macrophage-depleted mice. However, loss of macrophages 
significantly increased the percentage of IFN-γ+ CD8+ T cells 
compared to control animals 4 DPI. These results suggest that loss 
of macrophages significantly increases the production of IFN-γ 
by CD8+ T-cells.
secondary immune responses 
significantly increase the number of 
P. murina-specific Bone Marrow Plasma 
cells and P. murina-specific igg enhances 
Macrophage Killing
We next wanted to assess if infection with Pneumocystis gener-
ates long-lived bone marrow plasma cells and if Pneumocystis-
specific antibodies enhance macrophage-mediated killing. Mice 
were infected with P. murina and depleted of CD4+ T-cells every 
6 days with depletion occurring prior to secondary infection (2°), 
FigUre 6 | Pneumocystis pneumonia significantly increases the level of P. murina-specific bone marrow plasma cells and P. murina-specific igg 
enhances macrophage killing. C57BL/6 mice were infected with P. murina and depleted of CD4+ T-cells every 6 days with depletion occurring prior to secondary 
infection (2°). (a) Representative gating strategy used for flow cytometry analysis. (B) The absolute number of bone marrow plasma cell significantly increases in 
P. murina infected animals. (c) Bone marrow plasma cells isolated from infected animals secreted high levels of P. murina-specific IgG. (c-1) Representative 
micrograph of bone marrow plasma cells isolated from infected animals. (D) P. murina-specific IgG in the serum was assayed by ELISA. (e) P. murina-specific IgG 
enhanced in vitro killing of P. murina by macrophages in a dose-dependent manner. Dots and bars represent mean ± SEM, N = 10 at each time points, * indicates 
P < 0.05, for the indicated comparisons for each of the indicated time point, by Kruskal–Wallis ANOVA followed by Dunn’s posttest.
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as described previously. The gating strategy used to flow sort 
BMPCs is described in Figure 6A. We first examined the abso-
lute number of bone marrow plasma cells in P. murina-infected 
animals and found that there was a significant increase in the 
amount of obtainable BMPCs relative to sham-infected controls 
(Figure 6B). Additionally, loss of CD4+ T-cells prior to secondary 
infection did not significantly affect the number of BMPCs. To 
confirm that the BMPCs isolated from infected mice secreted 
Pneumocystis-specific IgG, BMPCs were grown in coculture with 
MSCs, and the levels of P. murina-specific IgG in the supernatant 
were determined. We found that the bone marrow plasma cells 
isolated from infected animals secreted high levels of P. murina-
specific IgG (Figure 6C). A representative micrograph of bone 
marrow plasma cells isolated from infected animals is shown in 
Figure 6C and 1. We also found that the levels of P. murina-specific 
IgG in the serum was significantly increased in infected animals 
and was correlated with the increase in BMPCs (Figure  6D). 
Finally, we assessed the capacity of P. murina-specific IgG to 
enhance in vitro killing of P. murina by macrophages. We found 
that IgG from infected animals significantly increased the kill-
ing of P. murina by macrophages, in a dose-dependent manner 
(Figure 6E).
DiscUssiOn
Exposure to Pneumocystis is ubiquitous in humans and occurs at 
an early age, around 2 years of life (2, 9). However, Pneumocystis 
pneumonia is a major cause of morbidity and mortality among 
immunocompromised patients, especially in the context of HIV/
AIDS. This is surprising as the majority of adults have detectable 
levels of Pneumocystis-specific antibodies at the time of infection 
(10). These data suggest that immunological memory against 
Pneumocystis in humans may be insufficient or suboptimal, that 
other cellular populations (non-CD4+ T-cells) may be required 
for maximal secondary immune responses, or that HIV infection 
disrupts immune memory responses. Despite the fact that nearly 
all humans are exposed to Pneumocystis, there remains a paucity 
of data investigating the immunological memory and secondary 
immune response against Pneumocystis, especially in the context 
of CD4+ T-cell depletion. Therefore, we sought to investigate 
immunological memory against Pneumocystis in the context of 
CD4+ T-cell depletion.
Our current experiments demonstrate that secondary 
immune responses to Pneumocystis do not require CD4+ T-cells, 
which is consistent with the previous reports (3, 11, 12). However, 
we further went on to investigate other cellular populations that 
could be involved in secondary immune memory responses by 
investigating the role of CD8+ T-cells and macrophages during 
the immune memory recall response to Pneumocystis. We found 
that loss of CD8+ T-cells or macrophages alone or in the context 
of CD4+ T-cell depletion significantly impaired the ability of 
the host to clear Pneumocystis infection. We also evaluated the 
cellular phenotypes associated with CD4+ T-cells and CD8+ 
T-cells during secondary immune responses, in the context of 
CD4+ T-cell depletion, CD8+ T-cell depletion, and alveolar mac-
rophage depletion. Loss of CD8+ T-cells or macrophages delayed 
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the production of IFN-γ by CD4+ T-cells; however, by 4  DPI, 
the production is increased, which is likely due to increased 
fungal burden and the host trying to mediate a more robust 
immune response. While CD4+ T-cells are absolutely critical 
for resolution of Pneumocystis through the coordination of host 
inflammatory responses by recruitment and activation of effec-
tor cells, which ultimately lead to the elimination of the organism 
during a primary infection, loss of CD4+ T-cells does not render 
a previously exposed animal susceptible to re-infection with 
Pneumocystis (1).
Additionally, loss of CD4+ T-cells does not affect the immune 
memory response of CD8+ T-cells, but loss of macrophages or 
loss of both macrophages and CD4+ T-cells drives the CD8+ 
T-cell response toward terminally differentiated effector memory 
phenotype. Loss of macrophages also significantly increased 
the production of IFN-γ by CD8+ T-cells, which is likely due to 
increased fungal burden. Several studies have examined the role 
of CD8+ T-cells during primary infection, yet the role of CD8+ 
T-cells, particularly in the setting of CD4+ T-cell deficiency, 
remains controversial. Specifically, Gigliotti et al. demonstrated 
that there was no difference in organism burden in CD4+ T-cell 
depleted vs. CD4+ and CD8+ T-cell-depleted animals, indicat-
ing that CD8+ T cells are not involved in fungal clearance (13). 
However, other studies have shown that CD8+ T cells can be pro-
tective against Pneumocystis infection, though this is dependent 
on their cytotoxic phenotype, which is defined by high levels of 
endogenous IFN-γ production (14). In fact, animal studies have 
demonstrated that delivery of IFN-γ via aerosol or by an adeno-
viral-mediated gene transfer results in clearance of Pneumocystis 
in the absence of CD4+ T cells, and this was associated with 
an increase in recruited IFN-γ-producing CD8+ T cells (15). 
Further, McAllister et al. showed that IFN-γ stimulated CD8+ T 
cells from Pneumocystis-infected CD4-depleted mice enhanced 
macrophage-mediated in vitro killing (16). These studies suggest 
that the role of CD8+ T-cells during a primary infection is to 
enhance macrophage-mediated killing through the production 
of IFN-γ, which is consistent with our data assessing the role of 
CD8+ T-cells in secondary immune responses. More precisely, we 
observe loss of macrophages, but not CD4+ T-cells, significantly 
increases the production of IFN-γ by CD8+ T-cells and drives 
CD8+ T-cells toward a terminally differentiated effector memory 
phenotype [a cellular phenotype characterized by high levels of 
IFN-γ production (17)], all of which suggest that CD8+ T-cells 
upregulate IFN-γ responses to combat Pneumocystis infection 
during a secondary immune response. While we cannot fully 
explain these results, we believe that the increased fungal burden 
seen in macrophage-depleted mice results in increased activation 
of the remaining immune effector cells in the lung, including 
IFN-γ producing CD8+ T-cells.
Finally, we found that Pneumocystis-specific IgG from infected 
animals significantly increases the killing of P. murina by mac-
rophages, in a dose-dependent manner. Alveolar macrophages 
are critical in optimal host defense against Pneumocystis as 
they have ability to directly kill both trophozoites and cysts (18, 
19). Several studies have shown an inverse correlation between 
macrophage numbers and severity of Pneumocystis infection 
(20, 21). Specifically, animal studies demonstrate that chemical 
depletion of alveolar macrophages in normal rats, followed by 
Pneumocystis challenge results in significantly higher fungal load 
in the lungs compared with non-depleted mice (22). However, lit-
tle data exist examining the role of macrophages during secondary 
immune responses to Pneumocystis. Macrophages utilize several 
mechanisms to kill Pneumocystis (i.e., nitric oxide release and 
opsonization) (23). More precisely, alveolar macrophages primed 
by IFN-γ produce a nitrosative burst that is toxic to Pneumocystis 
(23). Additionally, Roths and Sidman found that anti-Pneumo-
cystis serum was effective at reducing the number of organisms 
in all stages of Pneumocystis infection in SCID mice (24). Taken 
together, these studies suggest that macrophage-mediated killing 
of Pneumocystis is mediated, in part, by IFN-γ stimulation and 
opsonization via Pneumocystis-specific IgG, which is consistent 
with our data that demonstrate that Pneumocystis-specific IgG 
from infected animals significantly increases the killing of P. 
murina by macrophages, and that loss of macrophages signifi-
cantly increases the production of IFN-γ by CD8+ T-cells.
The host immune memory response during Pneumocystis 
infection involves a complex interaction between CD4+ T-cells, 
CD8+ T-cells, alveolar macrophages, and soluble factors that 
together facilitate clearance of the infection. Our data suggest 
that the immune memory response to Pneumocystis is, in part, 
mediated by CD8+ T-cells, macrophages, and Pneumocystis-
specific IgG, but that CD4+ T-cells play little role. In addition, 
infection with Pneumocystis significantly increases the levels 
of Pneumocystis-specific long-lived BMPCs, and numbers of 
BMPCs are not significantly affected by loss of CD4+ T-cells. Taken 
together, these results suggest that investigation of immune cell 
populations other than CD4+ T-cells during immune responses to 
Pneumocystis in the HIV+ population may be extremely valuable.
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